What Are the Treatment Options for Sudden Sensorineural Hearing Loss?
Aug 20, 2021
Source: Cainiu Health
Dr. Yu Caihong
Introduction
What are the treatment options for sudden sensorineural hearing loss (SSNHL)?
Current treatment strategies involve a comprehensive, multimodal approach, including glucocorticoids, thrombolytic and anticoagulant agents, neurotrophic drugs, and hyperbaric oxygen therapy. Improving inner ear microcirculation and enhancing oxygen delivery constitute the cornerstone of SSNHL management. Additional specialized interventions may also be employed, such as stellate ganglion block, intratympanic corticosteroid injection, and acupuncture.
Currently, the most effective treatment approach is comprehensive therapy, including corticosteroids, thrombolytic and anticoagulant agents, neurotrophic drugs, and hyperbaric oxygen therapy. Given the evolving understanding of its pathogenesis, treatment for sudden sensorineural hearing loss (SSNHL) remains an active area of research.
Since cochlear ischemia and hypoxia represent critical pathophysiological mechanisms—and serve as the underlying basis for most cases—improving inner ear microcirculation and enhancing oxygen delivery constitute the cornerstone of current therapeutic strategies. Additional specialized interventions include stellate ganglion block, intratympanic corticosteroid administration, and acupuncture.
SSNHL may spontaneously resolve but also tends to recur. Poor prognostic factors include severe hearing loss at presentation and accompanying vertigo. Children and elderly patients generally exhibit poorer hearing recovery compared with other age groups. The timing of treatment initiation also influences prognosis: patients beginning treatment within 7–10 days of symptom onset typically achieve better outcomes. Reported overall improvement rates exceed 96%.
